Autopsy report · NCT00209131

Efficacy of Flomax to Improve Stone Passage Following Shock Wave Lithotripsy

“Due to frequent turnover of research coordinators and thus poor study accrual.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 5 months after it had already started.
• Ran for about 3 years 10 months before it stopped.
• 24 participants enrolled.
• Results were posted on the registry 3 years 5 months after it ended.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Emory University

Sponsor type

University, hospital or other

Conditions

Urolithiasis

Interventions

Flomax; Sugar pill

Participants

24

Sites

1

Countries

United States

Trials that died the same way

• Pembrolizumab + Idelalisib for Lung Cancer Study
  “The study was terminated due to poor accrual.” (72% match in meaning)
• Anti-gp100 Cells Plus ALVAC gp100 Vaccine to Treat Advanced Melanoma
  “The study was terminated due to low accrual.” (71% match in meaning)
• Bevacizumab (Avastin) in Unresectable/Recurrent Hemangioblastoma From Von-Hippel-Lindau Disease
  “Study terminated due to low accrual.” (70% match in meaning)
• Erwinase for Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) (IND 104224)
  “Study was terminated due to lack of accrual.” (69% match in meaning)
• Pilot Study of the Treatment of Vascular Endothelial Growth Factor(VEGF)Signaling Pathway Inhibitor-Induced Hypertension
  “Study has been terminated due to poor accrual.” (69% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.